Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil

por Diaz, Ricardo Sobhie, Hunter, James R., Camargo, Michelle, Dias, Danilo, Galinskas, Juliana, Nassar, Isabela, de Lima, Isaac Barbosa, Caldeira, Debora Bellini, Sucupira, Maria Cecilia, Schechter, Mauro
Publicado 2023